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Abstract
Background: Allergic asthma is a chronic inflammatory lung disease that is characterized by airway
hyperresponsiveness (AHR) to allergens, airway oedema, increased mucus secretion, excess production of T helper-
2 (Th2) cytokines, and eosinophil accumulation in the lungs. Corni fructus (CF) is a fruit of Cornus officinalis Sieb. Et.
Zucc. (Cornaceae) and has been used in traditional Korean medicine as an anti-inflammatory, analgesic, and
diuretic agent. To investigate the anti-asthmatic effects of CF and their underlying mechanism, we examined the
influence of CF on the development of pulmonary eosinophilic inflammation and airway hyperresponsiveness in a
mouse model of allergic asthma.
Methods: In this study, BALB/c mice were systemically sensitized to ovalbumin (OVA) by intraperitoneal (i.p.),
intratracheal (i.t.) injections and intranasal (i.n.) inhalation of OVA. We investigated the effect of CF on airway
hyperresponsiveness, pulmonary eosinophilic infiltration, various immune cell phenotypes, Th2 cytokine production,
and OVA-specific immunoglobulin E (IgE) production.
Results: The CF-treated groups showed suppressed eosinophil infiltration, allergic airway inflammation, and AHR
via reduced production of interleuin (IL) -5, IL-13, and OVA-specific IgE.
Conclusions: Our data suggest that the therapeutic effects of CF in asthma are mediated by reduced production
of Th2 cytokines (IL-5), eotaxin, and OVA-specific IgE and reduced eosinophil infiltration.
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Background
Allergic asthma generally presents with symptoms of
wheezing, coughing, breathlessness, and airway inflam-
mation. It is a chronic inflammatory disease of the air-
ways, characterized by airway eosinophilia and goblet
cell hyperplasia with mucus hypersecretion to inhaled
allergens and nonspecific stimuli [1,2]. In particular,
eosinophilic inflammation is considered the hallmark of
airway inflammation in asthma [3]. The inflammatory
process in allergic asthma is dominated by Th2 cells
that produce IL-4, IL-5, and IL-13 [4], which activate
eosinophils and induce the production of IgE by B cells
[5,6].
CF is a Korean traditional medicinal herb with tonic,
analgesic, and diuretic activity and has been commonly
used to facilitate liver and kidney function, reduce uri-
nation, and decrease perspiration. We previously
reported that CF has anti-allergic activity in mouse sple-
nic B cells and IC-2 mast cells [7]. Sung et al. [8]
reported that aqueous extracts of CF have anti-inflam-
matory and analgesic activities in murine RAW 264.7
macrophage cells. Moreover, Du et al. [9] reported that
the polysaccharides in crude and processed CF enhance
nonspecific immunity, specific humoral immunity, and
specific cellular immunity in immunosuppressed mice,
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and processing of CF with wine markedly increases the
activity of the polysaccharides. Other biological activities
of CF include hypoglycaemic, anti-neoplastic, and anti-
microbial effects, as well as the improvement of liver
and kidney function [10-12]. However, no study thus far
has addressed the anti-asthmatic and anti-inflammatory
activity of CF in vivo.
The aim of this study was to evaluate the effect of CF
extract on Th1 and Th2 cytokines as well as the devel-
opment of allergic airway inflammation and airway
hyperresponsiveness in a mouse model of allergic
asthma.
Methods
Plant material and preparation of extracts
CF samples were purchased from Wonju Jaeil Korean
Herbs Co. Ltd. (Wonju, Korea) in May 2011 and identi-
fied by Professor Young-Cheol Lee of the College of
Oriental Medicine at Sangji University in Wonju, Korea,
and a voucher specimen (CF) was deposited in our
laboratory (Department of Herbology, College of Orien-
tal Medicine, Sangji University Wonju 220-702, Republic
of Korea). The plant material (200 g) was extracted 3
times with H2O. The extract was then filtered and eva-
porated on a rotatory evaporator (Rotary evaporator,
BUCHI B-480, Switzerland) and finally dried using a
freeze drier (Freeze dryer, EYELA FDU-540, Japan) to
yield the extract CF (27.1 g). The yield (w/w) of the
extract was approximately 13.5%.
Animals
Five-week-old female BALB/c mice were obtained from
Daehan Biolink Co. LTD. (Eumsung, Republic of Korea).
Our study was approved by the committee for animal
welfare at Daejeon University. Moreover, all animal pro-
cedures were conducted in accordance with the guide-
lines of the Institutional Animal Care and Use
Committee of the Korea Research Institute of Bioscience
and Biotechnology (Daejeon, Republic of Korea).
OVA sensitization and inhalation
Based on a modification of a previously described proto-
col [13], OVA (500 μg/mL) in PBS was mixed with
equal volumes of 10% (w/v) aluminum potassium sul-
phate (alum; Sigma) in distilled water, incubated for 60
min at RT after pH adjustment to 6.5 by using 10 N
NaOH, and centrifuged at 750 × g for 5 min. The OVA/
alum pellet was resuspended to the original volume in
distilled water. As shown in Figure 1B, all mice were
immunized on 3 different days (i.e., 7, 14, or 21 days) by
i.p. injections of 0.2 mL alum-precipitated antigen con-
taining 100 μg of OVA (Sigma-Aldrich Korea, Korea)
bound to 4 mg of aluminum hydroxide (Sigma-Aldrich
Korea, Korea) in PBS. Seven days after the challenges
via i.t. injections of 100 μL (250 μg/mL) of OVA (on
day 21) in the back of the tongue for a marked influx of
leucocytes into the BALF, the mice were exposed to
aerosolized OVA for 30 min/day, 3 days/week for 5
weeks (at a flow rate of 250 L/min; 1% OVA in normal
saline for the first 4 weeks and 2% OVA in normal
saline for the last week). CF (50 and 200 mg/kg, Sigma-
Aldrich Korea, Korea) was orally administered 3 times a
week for the last 5 weeks. One day after the last OVA
exposure (2% OVA inhalation), the airway hyperrespon-
siveness was determined, and bronchoalveolar lavage
fluid (BALF), lung cells, and serum samples were col-
lected for further molecular analyses.
BALF
Immediately following the assessment of AHR, the mice
were killed with an i.p. injection of sodium pentobarbi-
tone (100 mg/kg). The trachea was cannulated, and
BALF was obtained by washing the airway lumen.
Briefly, cells of the lungs were recovered by flushing 1
mL of BALF (1 mM EDTA, 10% FBS, PBS) into the
lungs via the trachea. Total cell counts were determined
after 100 μL of fluid was cytospun onto glass slides
using a Cytospin centrifuge (Cellspin, Hanil,, Korea)
(400 × g for 4 min). Differential cell counts were per-
formed after staining with a Diff-Quik Stain Set (Baxter
Healthcare Corp., Miami, Florida, USA). The superna-
tant of the BALF was stored at -25°C for the determina-
tion of cytokine levels.
Digestion of pulmonary tissue and cell preparation
Single-cell suspensions from lung tissues and BALF were
isolated by mechanical disruption in RPMI 1640 medium
supplemented with 2 mM L-glutamine, 100 U/mL peni-
cillin, 100 μg/mL streptomycin, 50 μM 2-mercaptoetha-
nol, 20 mM HEPES, and 2% heat-inactivated foetal
bovine serum (FBS, GIBCO, Grand Island, NY). Briefly,
the lungs were removed from the thoracic cavity. After
mincing using sterile scalpels, the tissue was incubated in
PBS containing 1 mg/mL collagenase IV and 2 mg/mL
dispase for 40 min at 37°C in a sterile polypropylene
tube. After incubation, the lung tissue was vigorously
pipetted up and down to further dissolve the remaining
tissue clumps and then filtered using a 70-μm cell strai-
ner (Falcon, Le Pont de Claix, France). The total number
of cells was counted manually using a haemocytometer
chamber (Fisher), and 2-4 × 103 cells were spun onto
glass slides (Cytospin centrifuge, Cellspin, Hanil, Korea)
(400 × g for 4 min). Differential counting was performed
according to standard morphologic criteria.
Determination of AHR
AHR in the mice was estimated using a previously
described method with modifications [13]. A Buxco
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system (Biosystem XA; Buxco Electronics Inc, Troy,
Conn) was used to evaluate the extent of airway con-
striction in different groups of mice according to the
protocol described previously.
The Penh value is equal to Pause × PEF/PIF, where
Pause = (Te-Tr)/Tr (PIF, peak inspiratory flow; PEF:
peak expiratory flow; Te, expiratory time; Tr, relaxation
time). In this experiment, the mice were aerosolized
with OVA for 30 min/day, 3 days/week for 5 weeks. At
24 h after the final inhalation, the mice were given aero-
solized normal saline, followed serially by 3.125, 6.25,
12.5, 25, and 50 mg/mL methacholine (Sigma). The air-
way reactivity was then monitored for 30 min. Differ-
ences in the Penh value between the groups were
evaluated using Mann-Whitney test.
Haematoxylin-eosin (H&E), masson-trichrome (M-T),
periodic acid-Schiff (PAS) staining and BALF cytospin
The BALB/c mice were treated with OVA for 5 weeks
(3 times a week) to induce asthma. Two experimental
groups were treated with different concentrations of CF
for the last 5 weeks (5 times/week). At the end of the
Figure 1 Effect of CF on airway hyperresponsiveness in OVA-challenged mice. Mice were sensitized and challenged by OVA as described
in the Materials and methods. The airway responsiveness to aerosolized methacholine was measured with a Buxco box, as described in the
Materials and methods. The mice were placed in the main chamber and were nebulized first with PBS and then with increasing doses (3.125 to
50 mg/mL) of methacholine for 3 min for each nebulisation (A). Schematic representation showing the protocol to induce asthma model (B).
The data represent the mean ± SEM from 5 independent experiments. *P < 0.05, **P < 0.01 for the control goup versus the CF-treated groups.
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experiment, the lungs were removed and analyzed histo-
logically using a modification of a previously described
protocol [13].
Briefly, the lung tissue was embedded in paraffin, cut
into 3-μm-thick sections, and stained with H&E or M-T
solution. The tissue was subsequently mounted and cov-
erslipped with Dako mounting medium (Dakocytoma-
tion; Carpinteria, CA). The degree of inflammatory cell
infiltration in the airway was scored in a double-blind
manner by 2 independent observers. The degree of peri-
bronchiolar and perivascular inflammation was evalu-
ated on a subjective scale of 0-2, as modified from a
previously described protocol [13]. Periodic acid-Schiff
(PAS) staining was performed to identify mucus secre-
tion in the lung tissue. Frozen sections (30-mm thick)
were generated for each tissue. The sections were
mounted on gelatin-coated slides, stained with PAS
reagents, dehydrated, and coverslipped with permount.
The PAS-positive goblet cells were counted manually,
normalized against the length of the bronchial epithelial
perimeter on the basal side, and expressed as the num-
ber of PAS-positive cells per millimetre of basement
membrane.
Antibodies and flow cytometric analysis
All antibodies (anti-CD3, CCR3, CD11b, Gr-1) for flow
cytometric analysis were purchased from Becton Dickin-
son (BD) PharMingen (San Diego, CA). Cells from lung
tissues and BALF were stained with the indicated anti-
bodies in a staining buffer (PBS containing 1% FBS and
0.01% NaN3) for 10 min on ice, and analyzed by 2-col-
our flow cytometry on a FACSCalibur using CellQuest
software (BD Biosciences, Mountain View, CA).
Enzyme-linked immunosorbent assay (ELISA)
Interleukin (IL-4, IL-5, and IL-13) and IFN-g production
in the BALF and the presence of anti-OVA IgE in the
serum of the mice (n = 5) were analysed by ELISA
according to the manufacturer’s instructions with a
monoclonal antibody-based mouse interleukin ELISA kit
(R&D system). For OVA-specific IL-4 and IFN-g pro-
duction, spleen cells were suspended in RPMI 1640
medium supplemented with 2 mM L-glutamine and 5%
foetal bovine serum and then cultured for 48 h at a den-
sity of 1 × 105 cells/well in 96-well culture plates (Corn-
ing Inc, Cambridge, Mass) with or without 1 μg/mL of
OVA in a humidified atmosphere of 5% CO2 in air at
37°C. The culture supernatants were collected and
assayed for IFN-g and IL-4 induced by OVA by using
ELISA. All data represent the mean and standard devia-
tion of at least 3 separate replications and were com-
pared using analysis of variance (ANOVA).
Fingerprint high performance liquid chromatography
(HPLC) analysis
Chemicals and reagents
Morroniside was purchased from NPC BioTechnology
(Yeongi, Korea), and loganin and ursolic acid were pur-
chased from Sigma (USA). The purity of each com-
pound was determined to be above 98% by HPLC
analysis. The HPLC-grade reagents acetonitrile and
water were obtained from J.T. Baker (Phillipsburg, NJ,
USA). The other chemicals were of analytical grade.
Chromatographic system and conditions
The analysis was performed using a Waters HPLC sys-
tem equipped with a Waters 600 pump, a Waters 996
PDA detector, an Empower system controller, and an
HPLC column (Optimapak C18 column, 4.6 × 250 mm,
i.d., 5-μm particle size). The mobile phase for the HPLC
analysis consisted of water and acetonitrile (86:14 for
morroniside, loganin, and CF analyses; 10:90 for ursolic
acid and CF analysis). The column temperature was
maintained at 40°C. The analysis was performed using a
flow rate of 1.0 mL/min with PDA detection (240 nm
for morroniside and loganin analysis, 200 nm for ursolic
acid analysis). The injection volume was 20 μL.
Statistical analysis
The data were analyzed using a one-way ANOVA to
determine statistically significant variance between the
groups for each end point assessed. Statistical signifi-
cance between groups was then calculated by using the
nonparametric Mann-Whitney test followed by Dun-
nett’s multiple comparison test (IBM SPSS statistics ver-
sion 19.0 statistic software, Inc, IBM, USA). The
difference between the normal group and the control
group (OVA + vehicle) was obvious; for this reason, the
statistical significance between the normal group and
the control group is not shown in the figures and tables.
The results (presented as mean ± standard error of
mean) were defined as statistically significant for the fol-
lowing P values: < 0.05 (*), < 0.01 (**), or < 0.001 (***).
Results
Inhibitory effect of CF on AHR
In a mouse model of allergic asthma, we evaluated the
effects of CF delivered by nebulisation only or in combi-
nation with oral administration. Both CF treatments
were equally efficient for reducing AHR to methacho-
line, as determined by whole-body plethysmography
(Figure 1A).
The Penh value was measured using a Buxco system
on day 1 after the final inhalation, and the samples were
immediately collected. Methacholine treatment is useful
to determine the distinct effect of drugs on the Penh
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value through induction of AHR. Compared with nor-
mal mice, in OVA-sensitized mice, the dose-response
curve of the Penh value was shifted to the left (Figure
1A). As shown in Figure 1A, relative to animals sensi-
tized with OVA (control group), the AHR to methacho-
line was reduced in the CF-treated (50, 200 mg/kg)
mice (P < 0.01, P < 0.05).
Histological analysis of lung sections
As shown in Figure 2, the inflammation in the peri-
bronchial and perivascular regions of mice receiving
CF significantly decreased compared with that in mice
in the OVA group. The OVA-challenged mice and CF-
treated mice showed inflammatory histological changes
when compared with saline-challenged normal mice.
We also found infiltration of leukocytes in sections of
the lungs from OVA-challenged control mice as well
as a distinct inflammatory infiltration and erosion in
the peribronchial and perivascular areas. The peribron-
chial and perivascular inflammatory infiltrate consisted
of eosinophils and mast cells that were mixed with
lymphocytes. Eosinophil infiltration was mainly
observed in the peribronchial regions of the lung. In
contrast, histological sections from CF-treated mice
indicated reduced airway inflammation in the lung tis-
sue (Figure 2).
To investigate the presence of mucus in the airway,
PAS-positive and PAS-negative epithelial cells were ana-
lyzed in individual bronchioles. Goblet cell hyperplasia
and mucus hyperproduction were evaluated by means of
PAS staining and quantification of PAS-stained cells.
The OVA-challenged control mice showed significantly
increased numbers of PAS-positive cells compared with
saline-challenged normal mice; moreover, a greater
Figure 2 Effect of CF on airway inflammation (H&E, M-T, and PAS staining) in lung tissue and BALF of OVA-induced asthmatic mice. At
the end of the experiment, the lungs were fixed, and a histologic analysis was performed. Lung sections were obtained for normal and
asthmatic mice treated with vehicle (control), CF (50 mg/kg), and CF (200 mg/kg). H&E: hematoxylin-eosin stain, M-T: Masson trichrome stain,
PAS: periodic acid-Schiff Stain, N: Normal BALB/c mice, CT (control): Ovalbumin inhalation + vehicle, OVA + CF (50, 200 mg/kg).
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reduction in the mean number of PAS-stained goblet
cells was observed in the CF-treated (50, 200 mg/kg)
asthma mice than in the OVA-sensitized/challenged
mice (Figure 2).
Inhibitory effect of CF on airway eosinophil accumulation
and influx of inflammatory cells into the lungs and BALF
In total, 2.19 ± 0.39 × 107 cells were obtained from
lungs of the saline-challenged group; few eosinophils
were detected in this group. In contrast, the total num-
ber of lung cells (5.58 ± 0.3 × 107) and eosinophils in
the BALF cytospin of the OVA-challenged mice was sig-
nificantly higher than that in the saline-challenged
group.
The total number of lung cells was significantly
reduced in CF-treated (50, 200 mg/kg) mice compared
with control mice; moreover, CF treatment (50, 200 mg/
kg) decreased the absolute number of eosinophils in the
BALF as well as neutrophils and eosinophils in the
PBMC (Figure 3C, D, E).
Inhibitory effect of CF on the absolute number of
immune cell sub-types in OVA-induced asthmatic lungs
and BALF
Flow cytometric analysis was used to evaluate the effect
of CF on immune cell sub-types. The number of CD3-,
CCR3-, CD11b-, and Gr-1-positive cells in the lungs
and BALF of OVA-challenged mice was higher than
that in the saline-treated group, and generally, the num-
ber in CF-treated mice was significantly lower than that
in the OVA-challenged mice (Figure 4).
The effects of CF on leukocyte subsets in the lungs
and BALF of OVA-treated mice, compared with the
control group, included changes in the number of Gr-1
+/CD11b+ granulocytes as well as CD3-/CCR3+ eosino-
phils; further, the decreases in CD3-/CCR3+ eosinophils
were accompanied by concurrent decreases in eosino-
phils in the BALF (Figure 3C).
Inhibition of Th2 cytokines (in vivo and in vitro) and
OVA-specific IgE production in BALF and serum
To determine whether CF influenced Th2 cytokine
secretion in the BALF, the levels of IL-4, IL-5, and IL-
13 were measured using ELISA after the final challenge.
As shown in Figure 5A and 5B, the IL-5 and IL-13
levels were significantly reduced in CF-treated (200 mg/
kg) mice and in the spleen cell-culture supernatant. An
important component of the allergic asthma model is
the production of OVA-specific IgE. Therefore, the
levels of anti-OVA IgE were measured in serum from
the OVA-challenged mice as well as the mice treated
with PBS and CF. OVA-specific IgE levels in the serum
from OVA-induced asthmatic mice were significantly
higher than those in the serum from the normal mice
(PBS only). Further, the CF-treated mice had signifi-
cantly reduced levels of OVA-specific IgE (Figure 5C).
We also measured IL-4 and IFN-g in the culture super-
natants by ELISA and found that CF (200 mg/kg) inhib-
ited Th2 cytokine (IL-4) production and increased Th1
cytokine (IFN-g) levels in splenocytes (Figure 5D).
HPLC analysis of morroniside, loganin, and ursolic acid
from CF-treated mice
The retention times of morroniside, loganin, and ursolic
acid were approximately 5.9 min, 9.9 min, and 8.3 min,
respectively. Figure 6 shows the chromatograms of refer-
ence compounds and the C. officinalis extract; the elu-
ent was detected at 240 nm. The peaks of the 3 major
components were identified as morroniside, loganin, and
ursolic acid.
Discussion
In allergic asthma, the activation of allergen-induced
Th2 cells in the lungs leads to eosinophilic lung inflam-
mation, increased secretion of mucus, and recurring
bronchospasm. Eventually, with repeated allergen expo-
sure, the bronchial smooth muscle and basement mem-
brane thicken, lung tissue is destroyed, and lung
function is impaired [14]. Activated T lymphocytes in
the airways secrete the Th2 cytokine IL-5, which regu-
lates eosinophilic inflammation by regulating the prolif-
eration, differentiation, and activation of eosinophils
[15,16].
Previous studies have shown that Corni fructus can
control airway allergy and inflammation [17] and that
its main components, ursolic acid and oleanolic acid,
have anti-inflammatory and anti-oxidative effects
[18-20]. Ursolic acid influences basal airway mucin
release [21], and ursolic acid and oleanolic acid have
been reported to affect adenosine triphosphate (ATP)-
induced airway mucin release from epithelial cells of the
tracheal surface of cultured hamster [22]. Other studies
have showed that CF has anti-diabetic activity in rats
with streptozotocin-induced diabetes [23,24]. More than
150 compounds have been isolated from CF [25], and
some components (e.g., ursolic acid and oleanic acid)
have shown anti-diabetic effects [26,27]. However, the
exact mechanisms underlying the biological efficacy of
CF remain unclear, and its influence has not been stu-
died thus far in an asthma model.
The recruitment of eosinophils to the airways is a
characteristic of asthma, and the degree of eosinophilia
is correlated with the severity of the disease. Eosinophils
are thought to play a major role in AHR [28]. CF pre-
vented the development of AHR (Figure 1A), lung
inflammation (Figure 2), and airway eosinophilia (Fig-
ures 3 and 4) and decreased the level of Th2 cytokines
(IL-5 and IL-13) (Figure 5A) in the BALF. These results
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Figure 3 Effects of CF on total lung cells, total BALF cells, eosinophils in the BALF, and PBMCs. As described in the Materials and
methods, the lung and BALF were harvested 24 h after the last OVA challenge. The total inflammatory cell numbers in the lung and BALF were
counted, and cell classification was performed on a minimum of 200 cells to classify lymphocytes. The results are expressed as the mean ± SEM
(n = 5). The statistical significance of differences between control and treatment groups was assessed by ANOVA or the nonparametric Mann-
Whitney test followed by Dunnett’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). N: Normal BALB/c mice, CT: Ovalbumin
inhalation + vehicle, OVA + CF (50, 200 mg/kg).
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Figure 4 FACS analysis of various immune cell sub-types in the lung and BALF. The absolute numbers of various immune cell subtypes in
the lung were counted (A, B) (described in Materials and methods). The lung and BALF cells were stained with FITC-conjugated mAb to CD3
and CD11b as well as PE-conjugated mAb to Gr-1 and CCR3. A dot-plot pattern is shown for the representative flow cytometric profile for the
gated CD3-/CCR3+ and Gr-1+/CD11b + cells (C, D). The results are expressed as the mean ± SEM (n = 5). The statistical significance of
differences between the control and treatment groups was assessed by ANOVA or the nonparametric Mann-Whitney test followed by Dunnett’s
multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). N: Normal BALB/c mice, CT: Ovalbumin inhalation + vehicle, OVA + CF (50, 200
mg/kg).
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show that CF inhibits lung allergic responses in the
OVA-induced asthma model.
Asthma causes immune abnormalities in various cell
populations. Thus, another goal of asthma research is to
evaluate asthma-related changes in specific cell subpo-
pulations. In the present study, immunophenotyping by
flow cytometry showed a similar pattern as total lym-
phocyte numbers in the BALF and lungs. The effects of
CF on leukocyte subsets in the lungs and BALF of asth-
matic mice included changes in the number of Gr-1
+/CD11b+ granulocytes and CD3-/CCR3+ eosinophils
compared with the control group (Figure 4), and the
decrease in CD3-/CCR3+ eosinophils was accompanied
by concurrent decreases in eosinophils in the BALF
(Figure 2). CF also inhibited B-cell-dependent produc-
tion of OVA-specific IgE in the serum (Figure 5C).
CC chemokine receptor 3 (CCR3) is expressed on
eosinophils, mast cell (MC), basophils, and a subset of
Th2 lymphocytes [29]. Eosinophils are attracted via
CCR3 to chemoattractants such as eotaxin released in
the airways of asthmatic patients [30]. The inhibition of
pulmonary eosinophilia by CCR3 receptor blockade
using certain antagonists may reduce inflammation and
AHR in asthma. Moreover, eosinophils express Gr-1;
Figure 5 Effect of CF on Th2 cytokines (IL-5, IL-13) in the BALF and OVA-specific IgE in the serum, and immunomodulatory effects of
CF on OVA-specific Th1/Th2 cytokines produced by spleen cells (described in Materials and methods). The results are expressed as the
mean ± SEM (n = 5). The statistical significance of differences between the control and treatment groups was assessed by ANOVA or the
nonparametric Mann-Whitney test followed by Dunnett’s multiple comparison test (*P < 0.05, **P < 0.01, ***P < 0.001). N: Normal BALB/c mice,
CT: Ovalbumin inhalation + vehicle, OVA + CF (50, 200 mg/kg).
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therefore, eosinophil populations may constitute a sub-
stantial portion of the CD11b + Gr-1+ cells. Our results
(Figure 4) showed that the number of Gr-1+ cells in the
in BALF and lung increased with OVA challenge but
significantly decreased with CF treatment.
We observed significant correlations between IL-5
levels and CCR3 expression on eosinophils. We
hypothesised that CF prevents AHR by downregulating
IL-5 production and thereby reducing eosinophilia.
Nuclear factor kappa B (NF-B) is a major family of
transcription factors that is activated during the inflam-
matory response in asthma. NF-B is a key transcrip-
tional regulator of multiple pro-inflammatory mediators
such as TNFa and interleukins, and enhanced activation
of NF-B has been implicated in asthma [31].
The synthesis of many inflammatory mediators such
as TNFa; IL-4; IL-5; IL-8; regulated upon activation,
normal T-cell-expressed and secreted (RANTES); and
eotaxins, which are thought to be important in asthma
and COPD pathogenesis, is regulated through the acti-
vation of p38 mitogen-activated protein kinase (MAPK)
[32]. p38 MAPK activates an inflammatory transcrip-
tome similar to that of NF-B and is activated in cells
of patients with severe asthma [33]. An antisense oligo-
nucleotide that blocks the expression of p38 MAPK
showed inhibitory efficacy in a murine asthma model
[34]. p38 MAPK plays a key role in the activation of
GATA-binding protein 3 (GATA3), a transcription fac-
tor that regulates Th2 cell differentiation and the
expression of Th2 cytokines [35]. The CF extract also
suppressed an increase in the NF-B levels [8]. An in
vivo study showed that CF extract suppressed the acetic
acid-induced writhing response in mice. An aqueous
extract of CF exerts anti-inflammatory and analgesic
effects by suppressing COX-2 and iNOS expression
through decreased NF-B binding [8].
According to a previous study [36], cornuside, a pri-
mary component of CF, decreases the LPS-stimulated
phosphorylation of MAPKs (ERK1/2, p38, and JNK1/2)
in a concentration-dependent manner. These results also
indicate that among MAPK subtypes, JNK1/2 is inhibited
most potently by cornuside. Many studies have suggested
that MAPKs can participate in the regulation of NF-B
transcriptional activity. The activation of p38 but not
ERK1/2 by LPS results in NF-B activation and subse-
quent iNOS and NO release in macrophages. It is reason-
able to assume that p38 suppression by cornuside inhibits
the NF-B pathway in LPS-treated RAW 264.7 cells [37].
The MUC5AC mucin protein is mainly expressed in
goblet cells in the airway surface epithelium [38], and
oleanolic acid and ursolic acid inhibit the production of
MUC5AC induced by epidermal growth factor (EGF)
and phorbol 12-myristate 13-acetate (PMA), respectively
[39]. Although the underlying mechanisms of action of
CF on airway inflammation and anti-asthmatic activity
are not clear at present, from the aforementioned
reports, it is likely that CF regulates the MAPK cascade
via the EGF receptor and/or possible regulators of the
NF-B signalling pathway.
The inhibitory effects of CF on airway inflammation,
hyperresponsiveness, and Th2 cytokine production
Figure 6 HPLC chromatogram of standard mixture (A) and C.
officinalis (B) at 240 nm. Morroniside (1), loganin (2). C. officinalis
and 2 standards were subjected to HPLC analysis. An Optimpak C18
(4.6 × 250 mm) column was eluted with water and acetonitrile
(86:14) at flow rate of 1.0 mL/min. The HPLC chromatogram is
shown for the ursolic acid standard (C) and C. officinalis (D) at 200
nm. C. officinalis and ursolic acid were subjected to HPLC analysis.
The Optimpak C18 (4.6 × 250 mm) column was eluted with water
and acetonitrile (10:90) at flow rate of 1.0 mL/min.
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might explain, at least in part, the traditional use of CF
as an anti-inflammatory agent and potential anti-asth-
matic therapy in Korean traditional medicine. It would
be valuable to identify natural products that specifically
inhibit airway inflammation, hyperresponsiveness, and
Th2 cytokine production. Although the precise mechan-
ism of action is not clear and requires further investiga-
tion, to our knowledge, this is the first study to show
that CF significantly inhibits airway inflammation and
hyperresponsiveness in a mouse model of allergic
asthma. Therefore, we propose that CF be used for the
treatment of pathologic inflammatory airway disorders
such as allergic asthma.
Conclusions
Our data indicate that CF has profound inhibitory effects
on airway inflammation in a mouse model of asthma,
and these effects were caused by the suppression of Th2
cytokines (IL-5), B cell-dependent production of OVA-
specific IgE, and eosinophil CCR3 expression. It is rea-
sonable to assume that the anti-inflammatory and anti-
asthmatic activity of CF might be mediated by the inhibi-
tion of the NF-kB pathway. Hence, CF may act as a
potential Th2 cytokine (IL-5) antagonist and have a ther-
apeutic effect on allergic asthma.
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